Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management.
Explore this paper's citation graph
Summary
An algorithm is developed for using cryoprecipitate, fresh frozen plasma, and platelets infusion with antifibrinolytic agents as a last alternative for hemorrhage and the role of platelet inhibition should be considered.
- Type
- review
- Published
- 1989-12-15
- Cited by
- 109
- References
- 66
- OpenAlex
- https://openalex.org/W1976972736
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11561435
Keywords
Medicine, Cryoprecipitate, Fresh frozen plasma, Hypofibrinogenemia, Myocardial infarction
References
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
- Optimal hematocrit value in critically ill postoperative patients.
- Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.
- Cardiovascular effects of protamine sulfate in man.
- Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.
- Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions.
- The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen.
- Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.
- INACTIVATION OF FACTOR Va BY PIASMIN
- On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
- Effect of propranolol on platelet function.
- Binding and activation of plasminogen on the platelet surface.
- Binding of plasminogen to cultured human endothelial cells.
- High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.
- Radioimmunoassay of factor V in human plasma and platelets.
- The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis.
- Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
- Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.
- URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS
Cited by
- Comparison of Recombinant Plasminogen Activator Inhibitor-1 and Epsilon Amino Caproic Acid in a Hemorrhagic Rabbit Model
- Pulmonary Embolism in the Intensive Care Unit
- Beidseitige akute retrobulbäre Raumforderung im Rahmen einer Thrombolysetherapie bei Myokardinfarkt — ein Fallbericht
- Comparative Effects of Staphylokinase and Alteplase in Rabbit Bleeding Time Models
- HEART's Original [症例] モンテプラーゼによる血栓溶解療法後にびまん性肺出血を来した急性心筋梗塞の1例
- Bleeding complications associated with cardiopulmonary bypass.
- Glycoprotein lib/lila receptor blockers in acute coronary syndromes
- Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
- Cryoprecipitate: the current state of knowledge.
- Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
- Monitoring thrombolytic therapy.
- Adverse drug events associated with disorders of coagulation
- Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
- Association of Bleeding and In-Hospital Mortality in Black and White Patients With ST-Segment–Elevation Myocardial Infarction Receiving Reperfusion
- Thrombolytic therapy and proteolysis of factor V.
- Diffuse intra-alveolar haemorrhage as a complication of thrombolytic therapy in acute myocardial infarction
- Counteracting the Effects of Anticoagulants and Antiplatelet Agents during Neurosurgical Emergencies
- Inhibition of the fibrinolytic and fibrinogenolytic activity of plasminogen activators in vitro by the antidotes ϵ-aminocaproic acid, tranexamic acid and aprotinin
- Clinical risks of thrombolytic therapy.
- Acute myocardial infarction. Reperfusion strategies.
Related papers
- Patient blood management and transfusion therapy for hemostasis.
- Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia—cryoprecipitate or fibrinogen concentrate?
- [Whether fibrinogen concentrates are necessary in Russia?].
- [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
- Hypofibrinogenemic Massive Transfusion Trauma Patients Experience Worse Outcomes
- A RARE CASE OF BLEEDING DIATHESIS